HomeGLS • NSE
add
Glenmark Life Sciences Ltd
Previous close
₹750.50
Day range
₹755.40 - ₹825.00
Year range
₹456.00 - ₹906.00
Market cap
99.51B INR
Avg Volume
93.08K
P/E ratio
19.21
Dividend yield
4.05%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 5.73B | 5.93% |
Operating expense | 1.71B | 21.27% |
Net income | 1.19B | 13.12% |
Net profit margin | 20.73 | 6.75% |
Earnings per share | — | — |
EBITDA | 1.69B | 17.89% |
Effective tax rate | 26.09% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.43B | 21.54% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 23.92B | — |
Shares outstanding | 122.56M | — |
Price to book | 3.84 | — |
Return on assets | — | — |
Return on capital | 16.53% | — |
Cash Flow
Net change in cash
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 1.19B | 13.12% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2011
Website
Employees
1,824